banner
LightNews
amartinezrocamd.bsky.social
Alexandra Martínez-Roca MD.
@amartinezrocamd.bsky.social
61 followers 93 following 4 posts
Hematologist @hospitalclinic.bsky.social At-home management, #bmtsm #leusm and #CARTcell. Opinions of my own. Colombian dreamer🇨🇴
Posts Media Videos Starter Packs
Pinned
amartinezrocamd.bsky.social
Alexandra Martínez-Roca MD. @amartinezrocamd.bsky.social · Dec 24
🤩Thrilled to share our latest study:

At-Home (AH) care program for Acute Myeloid Leukemia (AML) for patients undergoing induction therapy with Venetoclax + Azacitidine (VenAza) at @hospitalclinic.bsky.social

www.mdpi.com/2072-6694/16...
At-Home Care Program for Acute Myeloid Leukemia Induction Phase in Patients Treated with Venetoclax-Based Low-Intensity Regimens
Background: Even though venetoclax in combination with azacitidine (VenAza) is considered a low-intensity regimen, its patients present a high incidence of cytopenia and infections during the first co...
www.mdpi.com
2
amartinezrocamd.bsky.social
Alexandra Martínez-Roca MD. @amartinezrocamd.bsky.social · 1d
Un merecido reconocimiento al @drmiguelperales.bsky.social por su larga trayectoria.

Siempre dispuesto a compartir conocimientos y procurar que los residentes de España puedan visitar @mskcancercenter.bsky.social. Para mi una de las mejores experiencias de mi residencia.
👏Muchas felicidades👏
1 1 3
amartinezrocamd.bsky.social
Alexandra Martínez-Roca MD. @amartinezrocamd.bsky.social · Jun 13
Join us on sunday morning at #EHA25 for the EHA - EBMT Joint Symposium!

Yes, I know is early, but I’ll be sure to show you where the good coffee is 😜
1
Reposted by Alexandra Martínez-Roca MD.
fdezdelarrea.bsky.social
Carlos Fernández de Larrea @fdezdelarrea.bsky.social · Mar 14
🚀🧬 Forge your future in science at IDIBAPS and the Hospital Clínic of Barcelona! Join our pioneering CAR-T research team and work towards your PhD. We're seeking bright minds eager to advance cancer therapy.

🔗 www.clinicbarcelona.org/uploads/medi...

#CAR-T #MultipleMyeloma #CancerResearch 🧪🔬
www.clinicbarcelona.org
2
Reposted by Alexandra Martínez-Roca MD.
anand-88-patel.bsky.social
Anand Patel @anand-88-patel.bsky.social · Mar 2
an important publication highlighting how academic/community communication re recommendations can drive down early mortality in APL and preserve excellent longterm survival!

jamanetwork.com/journals/jam...
1 2
amartinezrocamd.bsky.social
Alexandra Martínez-Roca MD. @amartinezrocamd.bsky.social · Dec 24
🤩Thrilled to share our latest study:

At-Home (AH) care program for Acute Myeloid Leukemia (AML) for patients undergoing induction therapy with Venetoclax + Azacitidine (VenAza) at @hospitalclinic.bsky.social

www.mdpi.com/2072-6694/16...
At-Home Care Program for Acute Myeloid Leukemia Induction Phase in Patients Treated with Venetoclax-Based Low-Intensity Regimens
Background: Even though venetoclax in combination with azacitidine (VenAza) is considered a low-intensity regimen, its patients present a high incidence of cytopenia and infections during the first co...
www.mdpi.com
2
amartinezrocamd.bsky.social
Alexandra Martínez-Roca MD. @amartinezrocamd.bsky.social · Dec 8
Congratulations Alex!!!
1 1